Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,958 | 248 | 93.0% |
| Education | $374.07 | 6 | 7.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $643.85 | 26 | $0 (2024) |
| Astellas Pharma US Inc | $604.70 | 34 | $0 (2023) |
| PFIZER INC. | $515.98 | 28 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $493.33 | 21 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $420.51 | 22 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $374.86 | 19 | $0 (2024) |
| UROVANT SCIENCES INC | $297.39 | 16 | $0 (2022) |
| ABBVIE INC. | $225.97 | 9 | $0 (2024) |
| Myovant Sciences Inc. | $182.46 | 8 | $0 (2022) |
| 180 Medical, Inc. | $174.35 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $771.73 | 36 | Sumitomo Pharma America, Inc. ($140.03) |
| 2023 | $1,429 | 66 | Sumitomo Pharma America, Inc. ($280.48) |
| 2022 | $1,621 | 83 | Astellas Pharma US Inc ($255.34) |
| 2021 | $1,510 | 69 | Janssen Biotech, Inc. ($353.81) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Oncology | ||||||
| 09/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/17/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $19.65 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $21.96 | General |
| 07/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: HORMONE THERAPY | ||||||
| 06/10/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: UROLOGY | ||||||
| 05/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/17/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/15/2024 | 180 Medical, Inc. | LOFRIC ORIGO (Device) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: UROLOGICAL CARE | ||||||
| 05/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: UROLOGY | ||||||
| 04/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Oncology | ||||||
| 04/15/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: UROLOGY | ||||||
| 04/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,000 | 6,015 | $799,205 | $232,559 |
| 2022 | 21 | 3,643 | 11,265 | $976,683 | $309,809 |
| 2021 | 21 | 3,869 | 11,711 | $721,991 | $366,006 |
| 2020 | 19 | 3,708 | 10,698 | $708,328 | $361,692 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 882 | 1,462 | $334,798 | $77,500 | 23.1% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 92 | 1,326 | $116,688 | $45,599 | 39.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 24 | 168 | $84,336 | $22,366 | 26.5% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 93 | 309 | $54,075 | $21,258 | 39.3% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 92 | 510 | $44,880 | $17,538 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 193 | 193 | $54,619 | $12,134 | 22.2% |
| 51705 | Simple change of bladder tube | Office | 2023 | 13 | 59 | $7,611 | $3,630 | 47.7% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 92 | 102 | $8,976 | $3,508 | 39.1% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 92 | 102 | $8,976 | $3,508 | 39.1% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2023 | 92 | 102 | $8,976 | $3,508 | 39.1% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 92 | 102 | $8,976 | $3,508 | 39.1% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 92 | 102 | $8,976 | $3,508 | 39.1% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 30 | 85 | $13,600 | $3,145 | 23.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 581 | 783 | $7,830 | $3,048 | 38.9% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 30 | 30 | $8,490 | $2,169 | 25.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 154 | 199 | $5,373 | $1,543 | 28.7% |
| 53660 | Initial dilation of urethra in female | Office | 2023 | 17 | 32 | $6,336 | $1,472 | 23.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 50 | 51 | $3,060 | $1,164 | 38.0% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 50 | 51 | $4,080 | $921.50 | 22.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 158 | 162 | $1,296 | $552.42 | 42.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 17 | 20 | $1,700 | $451.19 | 26.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 50 | 51 | $5,049 | $403.50 | 8.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 14 | $504.00 | $126.23 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 969 | 1,594 | $348,079 | $87,220 | 25.1% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 147 | 2,184 | $191,464 | $75,688 | 39.5% |
About Miranda Thomas
Miranda Thomas is a Family healthcare provider based in Hagerstown, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2019. The National Provider Identifier (NPI) number assigned to this provider is 1427512318.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Miranda Thomas has received a total of $5,332 in payments from pharmaceutical and medical device companies, with $771.73 received in 2024. These payments were reported across 254 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,958).
As a Medicare-enrolled provider, Thomas has provided services to 14,220 Medicare beneficiaries, totaling 39,689 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Hagerstown, MD
- Active Since 01/25/2019
- Last Updated 02/12/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1427512318
Products in Payments
- GEMTESA (Drug) $636.61
- ERLEADA (Drug) $622.27
- XTANDI (Drug) $607.19
- Nubeqa (Drug) $493.33
- XIAFLEX (Biological) $337.42
- ORGOVYX (Drug) $263.75
- Myrbetriq (Drug) $223.33
- BOTOX (Biological) $189.05
- MYRBETRIQ (Drug) $168.21
- GentleCath (Device) $167.41
- PROLARIS (Device) $149.85
- JELMYTO (Drug) $136.11
- INTERSTIM (Device) $133.58
- PROVENGE (Drug) $93.92
- NOCDURNA (Drug) $77.92
- LUPRON DEPOT (Drug) $72.11
- Xtandi (Drug) $69.96
- XYOSTED (Drug) $69.68
- CAMCEVI (Drug) $67.74
- Axumin (Drug) $64.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Hagerstown
Joyce Lee, Crnp-F, CRNP-F
Family — Payments: $6,364
Mrs. Muna Bahsali, Crnp, CRNP
Family — Payments: $5,922
Julienne Kala, Np, NP
Family — Payments: $4,794
Dr. Michelle Walker, Dnp, DNP
Family — Payments: $4,754
Tara Baker
Family — Payments: $4,036
Mrs. Catherine Hays, Crnp-F, CRNP-F
Family — Payments: $3,392